184 related articles for article (PubMed ID: 25230694)
1. Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.
Peters I; Dubrowinskaja N; Tezval H; Kramer MW; von Klot CA; Hennenlotter J; Stenzl A; Scherer R; Kuczyk MA; Serth J
Target Oncol; 2015 Jun; 10(2):267-75. PubMed ID: 25230694
[TBL] [Abstract][Full Text] [Related]
2. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.
Li J; Sheng C; Li W; Zheng JH
Int J Clin Exp Pathol; 2014; 7(3):1147-53. PubMed ID: 24696731
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
5. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
9. Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma.
Liu Q; Rexiati M; Yang Y; Wang WG; Azhati B; Saimaiti W; Wang YJ
Med Oncol; 2014 Apr; 31(4):882. PubMed ID: 24554520
[TBL] [Abstract][Full Text] [Related]
10. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
11. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
[TBL] [Abstract][Full Text] [Related]
12. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages.
Ohmori S; Takai J; Ishijima Y; Suzuki M; Moriguchi T; Philipsen S; Yamamoto M; Ohneda K
Mol Cell Biol; 2012 Dec; 32(23):4742-55. PubMed ID: 22988301
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
14. Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma.
Peters I; Dubrowinskaja N; Kogosov M; Abbas M; Hennenlotter J; von Klot C; Merseburger AS; Stenzl A; Scherer R; Kuczyk MA; Serth J
BMC Cancer; 2014 Feb; 14():101. PubMed ID: 24533449
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.
Zhao JJ; Chen PJ; Duan RQ; Li KJ; Wang YZ; Li Y
Int J Clin Exp Pathol; 2014; 7(6):3318-23. PubMed ID: 25031755
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer.
Chen L; Jiang B; Wang Z; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
Med Oncol; 2013 Jun; 30(2):498. PubMed ID: 23423786
[TBL] [Abstract][Full Text] [Related]
17. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
Qi C; Ma H; Zhang HT; Gao JD; Xu Y
Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
[TBL] [Abstract][Full Text] [Related]
18. GATA2 is a critical transactivator for the human IL1RL1/ST2 promoter in mast cells/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1/ST2 gene expression.
Baba Y; Maeda K; Yashiro T; Inage E; Kasakura K; Suzuki R; Niyonsaba F; Hara M; Tanabe A; Ogawa H; Okumura K; Ohtsuka Y; Shimizu T; Nishiyama C
J Biol Chem; 2012 Sep; 287(39):32689-96. PubMed ID: 22865859
[TBL] [Abstract][Full Text] [Related]
19. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
[TBL] [Abstract][Full Text] [Related]
20. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
